High prevalence of SDHB mutations in head and neck paraganglioma in Belgium

Journal of Hypertension

Volumn 26, Issue 7, 2008, Pages 1395-1401

  Persu, Alexandre ^a,b   Hamoir, Marc ^a   Grégoire, Vincent ^b   Garin, Pierre ^c   Duvivier, Etienne ^d   Reychler, Hervé ^b   Chantrain, Gilbert ^e   Mortier, Geert ^f   Mourad, Michel ^a   Maiter, Dominique ^b   Vikkula, Miikka ^g  

^a Department of Cardiology ^*  (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^d HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^e SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g DE DUVE INSTITUTE   (Belgium)

Author keywords

Paraganglioma; Pheochromocytoma; Respiratory chain; RET; SDHB; SDHD; VHL

Indexed keywords

PROTEIN RET; PROTEIN SUBUNIT; SDHB PROTEIN; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN; MEMBRANE PROTEIN; SDHB PROTEIN, HUMAN; SDHC PROTEIN, HUMAN; SDHD PROTEIN, HUMAN;

ABDOMEN; ADULT; ARTICLE; BELGIUM; CANCER PATIENT; CAUDA EQUINA; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HEAD AND NECK TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PREVALENCE; PRIORITY JOURNAL; TUMOR GENE; TUMOR RECURRENCE; AGED; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; MUTATION; PEDIGREE; PHENOTYPE;

ADULT; AGED; BELGIUM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PARAGANGLIOMA; PEDIGREE; PHENOTYPE; PREVALENCE; SUCCINATE DEHYDROGENASE;

EID: 54449085369     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282ffdc54     Document Type: Article

References (37)

1. Rustin P, Munnich A, Rotig A. Succinate dehydrogenase and human diseases: new insights into a well known enzyme. Eur J Hum Genet 2002; 10:289-291.
2. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000; 287:848-851.
3. Astuti D, Douglas F, Lennard TW, Aligianis IA, Woodward ER, Evans DG, et al. Germline SDHD mutation in familial phaeochromocytoma. Lancet 2001; 357:1181-1182.
4. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000; 26:268-270.
5. Gimm O, Armanios M, Dziema H, Neumann HP, Eng C. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res 2000; 60:6822-6825.
6. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002; 346:1459-1466.
7. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 2003; 63:5615-5621.
8. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004; 292:943-951.
9. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005; 366:665-675.
10. Gimenez-Roqueplo AP, Lehnert H, Mannelli M, Neumann H, Opocher G, Maher ER, et al. Phaeochromocytoma, new genes and screening strategies. Clin Endocrinol (Oxford) 2006; 65:699-705.
11. Bayley JP, Devilee P, Taschner PE. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med Genet 2005; 6:39.
12. Bornstein SR, Gimenez-Roqueplo AP. Genetic testing in pheochromocytoma: increasing importance for clinical decision making. Ann N Y Acad Sci 2006; 1073:94-103.
13. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, et al. Clinical presentation and penetrance of pheochromocytoma/ paraganglioma syndromes. J Clin Endocrinol Metab 2006; 91.:827-836.
14. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab 2007; 3:92-102.
15. Boon LM, Brouillard P, Irrthum A, Karttunen L, Warman ML, Rudolph R, et al. A gene for inherited cutaneous venous anomalies ('glomangiomas') localizes to chromosome 1p21-22. Am JHum Genet 1999; 65:125-133.
16. Renard L, Godfraind C, Boon LM, Vikkula M. A novel mutation in the SDHD gene in a family with inherited paragangliomas-implications of genetic diagnosis for follow up and treatment. Head Neck 2003; 25:146-151.
17. Taschner PE, Jansen JC, Baysal BE, Bosch A, Rosenberg EH, Brocker- Vriends AH, et al. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer 2001; 31.:274-281.
18. Young AL, Baysal BE, Deb A, Young WF Jr. Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene. J Clin Endocrinol Metab 2002; 87:4101-4105.
19. Jeffery J, Devendra D, Farrugia J, Gardner D, Murphy MJ, Williams R, et al. Increased urinary dopamine excretion in association with bilateral carotid body tumours- clinical, biochemical and genetic findings. Ann Clin Biochem 2006; 43:156-160.
20. Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM, et al. High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. J Clin Endocrinol Metab 2006; 91.:4505-4509.
21. Mora J, Cascon A, Robledo M, Catala A. Pediatric paraganglioma: an early manifestation of an adult disease secondary to germline mutations. Pediatr Blood Cancer 2006; 47:785-789.
22. Cascon A, Ruiz-Llorente S, Fraga MF, Leton R, Telleria D, Sastre J, et al. Genetic and epigenetic profile of sporadic pheochromocytomas. J Med Genet 2004; 41:e30.
23. Pastore YD, Jelinek J, Ang S, Guan Y, Liu E, Jedlickova K, Krishnamurti L, et al. Mutations in the VHL gene in sporadic apparently congenital polycythemia. Blood 2003; 101:1591-1595.
24. Badenhop RF, Jansen JC, Fagan PA, Lord RS, Wang ZG, Foster WJ, et al. The prevalence of SDHB, SDHC, and SDHD mutations in patients with head and neck paraganglioma and association of mutations with clinical features. J Med Genet 2004; 41.:e99.
25. Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, et al. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. BMC Med Genet 2006; 7:1.
26. Milunsky JM, Maher TA, Michels VV, Milunsky A. Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma. Am J Med Genet 2001; 100:311-314.
27. Baysal BE, Willett-Brozick JE, Lawrence EC, Drovdlic CM, Savul SA, McLeod DR, et al. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet 2002; 39:178-183.
28. Schiavi F, Boedeker CC, Bausch B, Peczkowska M, Gomez CF, Strassburg T, et al. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 2005; 294:2057-2063.
29. Havekes B, Corssmit EP, Jansen JC, van der Mey AG, Vriends AH, Romijn JA. Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. J Clin Endocrinol Metab 2007; 92:1245-1248.
30. Cascon A, Ruiz-Llorente S, Cebrian A, Telleria D, Rivero JC, Diez JJ, et al. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma. Eur J Hum Genet 2002;10:457-461.
31. Riemann K, Sotlar K, Kupka S, Braun S, Zenner HP, Preyer S, et al. Chromosome 11. monosomy in conjunction with a mutated SDHD initiation codon in nonfamilial paraganglioma cases. CancerGenetCytogenet 2004; 150:128-135.
32. Castellano M, Mori L, Giacche M, Agliozzo E, Tosini R, Panarotto A, et al. Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients. Ann N Y Acad Sci 2006; 1073:156-165.
33. De Krijger RR, Petri BJ, Van Nederveen FH, Korpershoek E, De Herder WW, De Muinck Keizer-Schrama SM, et al. Frequent genetic changes in childhood pheochromocytomas. Ann NYAcadSci2006; 1073:166-176.
34. Pacak K and Eisenhofer G, editors. Pheochromocytoma: first international conference. Ann N Y Acad Sci; 2006; 1073.
35. Favier J, Briere JJ, Strompf L, Amar L, Filali M, Jeunemaitre X, et al. Hereditary paraganglioma/pheochromocytoma and inherited succinate dehydrogenase deficiency. Horm Res 2005; 63:171-179.
36. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005; 23:8812-8818.
37. Lima J, Feijao T, Ferreira da Silva A, Pereira-Castro I, Fernandez-Ballester G, et al. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical- pathological correlations. J Clin Endocrinol Metab 2007; 92:4853-4864.